CYTOXAN Trademark

Trademark Overview

On Saturday, June 19, 2021, a trademark application was filed for CYTOXAN with the United States Patent and Trademark Office. The USPTO has given the CYTOXAN trademark a serial number of 90783577. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 13, 2025. This trademark is owned by Ingenus Pharmaceuticals, LLC. The CYTOXAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in chemotherapy
cytoxan

General Information

Serial Number90783577
Word MarkCYTOXAN
Filing DateSaturday, June 19, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in chemotherapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 4, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIngenus Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressOrlando, FL 32839
Party NameIngenus Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressOrlando, FL 32839

Trademark Events

Event DateEvent Description
Wednesday, June 23, 2021NEW APPLICATION ENTERED
Saturday, September 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, March 10, 2022ASSIGNED TO EXAMINER
Monday, March 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 19, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 14, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 30, 2022SOU EXTENSION 1 FILED
Wednesday, November 30, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 30, 2022SOU EXTENSION 1 GRANTED
Tuesday, December 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 17, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 17, 2024SOU EXTENSION 4 FILED
Friday, May 17, 2024SOU EXTENSION 4 GRANTED
Monday, May 15, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 15, 2023SOU EXTENSION 2 FILED
Monday, May 15, 2023SOU EXTENSION 2 GRANTED
Wednesday, May 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 17, 2023SOU TEAS EXTENSION RECEIVED
Friday, November 17, 2023SOU EXTENSION 3 FILED
Friday, November 17, 2023SOU EXTENSION 3 GRANTED
Tuesday, November 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 13, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, January 13, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

cytoxan chemotherapy preparations pharmaceutical